Hence, it indicated that WPPs might attenuate sarcopenia in vivo through two distinct mechanisms: by activation of Akt/mTOR signaling pathway and by reduction of inflammation levels and oxidative stress associated with aging. The gene discussed is AKT1; the disease is sarcopenia.